Literature DB >> 34165721

CRISPR/Cas Technologies Applied to Pseudogenes.

Marianna Vitiello1,2, Laura Poliseno3,4.   

Abstract

Pseudogenes have been considered as nonfunctional copies of their parental genes for a long time. Indeed, they have been often defined "junk DNA" or "transcriptional noise." However, with the identification of their involvement in several biological processes, the necessity of their study is inevitably growing up. The manipulation of pseudogene expression is complicated by their high homology with parental genes and by the fact that most of them work at the transcriptional level as noncoding RNAs. With the advent of CRISPR/Cas technology, these problems can be overcome. Particularly, as we describe in this chapter, it is possible: To perform genome editing, obtaining the complete elimination of the pseudogene genomic sequence (knock-out), preventing pseudogene transcription, introducing specific mutations in the pseudogene sequence, or introducing a specific sequence (knock-in). To positively or negatively manipulate pseudogene transcription. To target pseudogene RNA and negatively regulate its expression. To edit pseudogene DNA and RNA and alter a specific sequence. Moreover, CRISPR/Cas technology can be used as an RNA Binding Protein system for molecular biology techniques (such as RNA immunoprecipitation and pull-down), as well as for transcript tracking and live imaging.

Entities:  

Keywords:  CRISPR/Cas system; CRISPRa; CRISPRi; Cas13; Cas9; Genome editing; Pseudogene; RCas9; RNA Immunoprecipitation; RNA editing; RNA pull-down; Transcript tracking

Year:  2021        PMID: 34165721     DOI: 10.1007/978-1-0716-1503-4_17

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  22 in total

1.  Biallelic insertion of a transcriptional terminator via the CRISPR/Cas9 system efficiently silences expression of protein-coding and non-coding RNA genes.

Authors:  Yangyang Liu; Xiao Han; Junting Yuan; Tuoyu Geng; Shihao Chen; Xuming Hu; Isabelle H Cui; Hengmi Cui
Journal:  J Biol Chem       Date:  2017-02-14       Impact factor: 5.157

2.  A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.

Authors:  Martin Jinek; Krzysztof Chylinski; Ines Fonfara; Michael Hauer; Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2012-06-28       Impact factor: 47.728

3.  Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression.

Authors:  Lei S Qi; Matthew H Larson; Luke A Gilbert; Jennifer A Doudna; Jonathan S Weissman; Adam P Arkin; Wendell A Lim
Journal:  Cell       Date:  2013-02-28       Impact factor: 41.582

4.  Precise gene deletion and replacement using the CRISPR/Cas9 system in human cells.

Authors:  Qiupeng Zheng; Xiaohong Cai; Meng How Tan; Steven Schaffert; Christopher P Arnold; Xue Gong; Chang-Zheng Chen; Shenglin Huang
Journal:  Biotechniques       Date:  2014-09-01       Impact factor: 1.993

5.  An enhanced CRISPR repressor for targeted mammalian gene regulation.

Authors:  Nan Cher Yeo; Alejandro Chavez; Alissa Lance-Byrne; Yingleong Chan; David Menn; Denitsa Milanova; Chih-Chung Kuo; Xiaoge Guo; Sumana Sharma; Angela Tung; Ryan J Cecchi; Marcelle Tuttle; Swechchha Pradhan; Elaine T Lim; Noah Davidsohn; Mo R Ebrahimkhani; James J Collins; Nathan E Lewis; Samira Kiani; George M Church
Journal:  Nat Methods       Date:  2018-07-16       Impact factor: 28.547

6.  DNA interrogation by the CRISPR RNA-guided endonuclease Cas9.

Authors:  Samuel H Sternberg; Sy Redding; Martin Jinek; Eric C Greene; Jennifer A Doudna
Journal:  Nature       Date:  2014-01-29       Impact factor: 49.962

7.  Sequence features associated with the cleavage efficiency of CRISPR/Cas9 system.

Authors:  Xiaoxi Liu; Ayaka Homma; Jamasb Sayadi; Shu Yang; Jun Ohashi; Toru Takumi
Journal:  Sci Rep       Date:  2016-01-27       Impact factor: 4.379

8.  PTENP1 is a ceRNA for PTEN: it's CRISPR clear.

Authors:  Marianna Vitiello; Monica Evangelista; Yang Zhang; Leonardo Salmena; Pier Paolo Pandolfi; Laura Poliseno
Journal:  J Hematol Oncol       Date:  2020-06-09       Impact factor: 17.388

9.  Effective CRISPR interference of an endogenous gene via a single transgene in mice.

Authors:  Ryan S MacLeod; Keisha M Cawley; Igor Gubrij; Intawat Nookaew; Melda Onal; Charles A O'Brien
Journal:  Sci Rep       Date:  2019-11-21       Impact factor: 4.379

10.  Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation.

Authors:  Luke A Gilbert; Max A Horlbeck; Britt Adamson; Jacqueline E Villalta; Yuwen Chen; Evan H Whitehead; Carla Guimaraes; Barbara Panning; Hidde L Ploegh; Michael C Bassik; Lei S Qi; Martin Kampmann; Jonathan S Weissman
Journal:  Cell       Date:  2014-10-09       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.